These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25737193)

  • 1. Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State.
    Orenes-Piñero E; Pineda J; Roldán V; Hernández-Romero D; Marco P; Tello-Montoliu A; Sogorb F; Valdés M; Lip GY; Marín F
    J Atheroscler Thromb; 2015; 22(6):610-7. PubMed ID: 25737193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
    Mannerås-Holm L; Baghaei F; Holm G; Janson PO; Ohlsson C; Lönn M; Stener-Victorin E
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1068-76. PubMed ID: 21252248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between obesity and a prothrombotic state: the Framingham Offspring Study.
    Rosito GA; D'Agostino RB; Massaro J; Lipinska I; Mittleman MA; Sutherland P; Wilson PW; Levy D; Muller JE; Tofler GH
    Thromb Haemost; 2004 Apr; 91(4):683-9. PubMed ID: 15045128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
    Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
    Pineda J; Marín F; Marco P; Roldán V; Valencia J; Ruiz-Nodar JM; Sogorb F; Lip GY
    Int J Cardiol; 2009 Aug; 136(2):222-5. PubMed ID: 18625524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.
    Cugno M; Castelli R; Mari D; Mozzi E; Zappa MA; Boscolo-Anzoletti M; Roviaro G; Mannucci PM
    Intern Emerg Med; 2012 Jun; 7(3):237-42. PubMed ID: 21249470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relations between overweight, thrombophilia and cardiovascular risk].
    Craveri A; Tornaghi G; Ranieri R; Paganardi L
    Ann Ital Med Int; 1990; 5(1):31-3. PubMed ID: 2119669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children.
    Mauras N; Delgiorno C; Kollman C; Bird K; Morgan M; Sweeten S; Balagopal P; Damaso L
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1060-8. PubMed ID: 20061420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects.
    von Känel R; Frey K; Fischer J
    Scand Cardiovasc J; 2004 Mar; 38(1):28-32. PubMed ID: 15204244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
    Mörtberg J; Blombäck M; Wallén Å; He S; Jacobson SH; Spaak J
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):401-7. PubMed ID: 26650459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.